Simultaneous assay of antiretroviral drugs in human plasma by high performance liquid chromatography;Dosage plasmatique des antirétroviraux par chromatographie liquide haute performance

Therapie

Volumn 57, Issue 2, 2002, Pages 169-174

  Titier, K ^a   Lagrange, F ^a   Pehourcq F ^a   Edno McHeik, L ^a   Moore, N ^a   Molimard, M ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Liquid chromatography; Nonnucleoside reverse transcriptase inhibitors; Protease inhibitors

Indexed keywords

ACETONITRILE; AMPRENAVIR; ANTIRETROVIRUS AGENT; BUFFER; EFAVIRENZ; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PHOSPHATE; RITONAVIR; SAQUINAVIR;

ACCURACY; CALIBRATION; CONFERENCE PAPER; DRUG DETERMINATION; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIQUID LIQUID EXTRACTION; PH; PRIORITY JOURNAL; REPRODUCIBILITY; ULTRAVIOLET RADIATION;

ANTI-HIV AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 0036319658     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
2. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection
3. Indinavir concentrations and antiviral effect
4. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
5. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
6. The relationship between ritonavir plasma levels and side-effects: Implications for therapeutic drug monitoring
7. Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography
8. Determination of L-735-524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching
9. Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection
10. Determination of indinavir, a HIV protease inhibitor in human plasma using ion-pair reversed-phase high-performance liquid chromatography
11. Determination of indinavir in plasma by solid phase extraction and column liquid chromatography
12. High-performance liquid chromatography method for determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma
13. Determination of saquinavir in human plasma, saliva and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection
14. Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography
15. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma
16. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high performance liquid chromatography after solid-phase extraction
17. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection
18. Simultaneous determination of the HIV protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high performance liquid chromatography
19. High performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patient during highly active antiretroviral therapy
20. Simultaneous determination of the five HIV-protease inhibitors: Amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by solid-phase extraction and column liquid chromatography
21. Sensitive and rapid method for the simultaneous quantification of HIV-protease inhibitors indinavir, nelfinavir, ritonavir and saquinavir in human plasma by reversed-phase liquid chromatography
22. Determination of twelve anti-retroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography
23. Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-1 infected patients
24. Drug monitoring of antiretroviral therapy for HIV-1 infection: Method validation and results of a pilot study
25. Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multi-oral dosing
26. The pharmacokinetics of combination therapy with nelfinavir plus nevirapine